DRD2 and Parkinson disease: Coherently, the null effect of the therapy manipulation we found could be interpreted in the view that, in the early phases of PD, dopamine neurotransmission is mainly involved in the modulation of flexibility processes depending on the activity of the D2 dopamine receptors in the caudate nucleus [29–31] and does not affect the on-line processing of consolidated information.